| Title |
Six-Month Efficacy and Toxicity Profile of BNT162b2 Vaccine in Cancer Patients with Solid TumorsSix-Month BNT162b2 Vaccine Outcomes in Solid Tumor Patients
|
|---|---|
| Published in |
Cancer Discovery, September 2021
|
| DOI | 10.1158/2159-8290.cd-21-1072 |
| Pubmed ID | |
| Authors |
Ithai Waldhorn, Roy Holland, Tal Goshen-Lago, Yelena Shirman, Moran Szwarcwort-Cohen, Anat Reiner-Benaim, Yael Shachor-Meyouhas, Khetam Hussein, Liana Fahoum, Avivit Peer, Ronit Almog, Yuval Shaked, Michael Halberthal, Irit Ben-Aharon |
X Demographics
The data shown below were collected from the profiles of 35 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 7 | 20% |
| Canada | 5 | 14% |
| Greece | 1 | 3% |
| Switzerland | 1 | 3% |
| Unknown | 21 | 60% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 26 | 74% |
| Scientists | 6 | 17% |
| Science communicators (journalists, bloggers, editors) | 2 | 6% |
| Practitioners (doctors, other healthcare professionals) | 1 | 3% |
Mendeley readers
The data shown below were compiled from readership statistics for 76 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 76 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 14 | 18% |
| Student > Master | 7 | 9% |
| Other | 5 | 7% |
| Researcher | 4 | 5% |
| Student > Ph. D. Student | 4 | 5% |
| Other | 9 | 12% |
| Unknown | 33 | 43% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 17 | 22% |
| Nursing and Health Professions | 5 | 7% |
| Biochemistry, Genetics and Molecular Biology | 4 | 5% |
| Pharmacology, Toxicology and Pharmaceutical Science | 2 | 3% |
| Agricultural and Biological Sciences | 2 | 3% |
| Other | 6 | 8% |
| Unknown | 40 | 53% |
Attention Score in Context
This research output has an Altmetric Attention Score of 274. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 23 March 2024.
All research outputs
#133,294
of 25,775,807 outputs
Outputs from Cancer Discovery
#50
of 4,154 outputs
Outputs of similar age
#3,772
of 436,154 outputs
Outputs of similar age from Cancer Discovery
#4
of 81 outputs
Altmetric has tracked 25,775,807 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 4,154 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 22.2. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 436,154 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 81 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 95% of its contemporaries.